abstract |
The present invention relates to compounds useful as Jun N-terminal kinase (JNK) inhibitors.n n n Compounds according to the invention are indazole derivatives represented by the formulan n n [Formula I]n n n n n n n n Wherein R 1 , R 2 and A are as defined in the detailed description of the invention.n n n The compounds of the present invention described above have applications that apply to a wide range of conditions where JNK inhibition is desired. Thus, as pharmaceutical compositions comprising one or more compounds selected from the above compounds are described in the detailed description of the invention, methods for treating such symptoms are also described in the detailed description of the invention. |